LONDON--(BUSINESS WIRE)--The UK genomic tools developer, RevoluGen Ltd. (RevoluGen or the Company), today announces that its divisional method patent has been granted by the UK Intellectual Patent ...
LONDON--(BUSINESS WIRE)--The UK genomic tools developer, RevoluGen Ltd., has entered into a global manufacturing arrangement with GE Healthcare Life Sciences which will ensure the supply chain for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback